Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc.

World Rank (Jan-05-2024)
5,928
Market Cap (Jan-05-2024)
1.871 Billion USD
World Rank (Jul-30-2023)
5,534
Market Cap (Jul-30-2023)
2.111 Billion USD
World Rank (Jan-07-2022)
5,877
Market Cap (Jan-07-2022)
2.220 Billion USD
World Rank (Jan-01-2021)
5,361
Market Cap (Jan-01-2021)
2.057 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
HRMY
Market Cap (Mar-08-2026)
1.64
Employee Count
156
Employee Count as of Date
As on 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
437 Million USD
Annual Operating Income in USD
120 Million USD
Annual Net Income in USD
181 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
673 Million USD
Total Liabilities in USD
271 Million USD
Total Equity in USD
402 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biopharmaceutical
Pharmaceutical
Biotechnology
Company Website
HARMONY BIOSCIENCES HOLDINGS, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile

Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

Facts About Company

The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

Annual Results Summary

HARMONY BIOSCIENCES HOLDINGS, INC - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022437120181
Dec-20213058734
Dec-202015916-63 (Loss)
Dec-20195-145 (Loss)-151 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 673 Million USD.

Total Liabilities as on Dec-2022 was 271 Million USD.

Total Equity as on Dec-2022 was 402 Million USD.

Founded Year
2017
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share